Lense, X.M. http://orcid.org/0009-0001-3302-7109
Hiemke, C.
Funk, C.S.M.
Havemann-Reinecke, U.
Hefner, G.
Menke, A.
Mössner, R.
Riemer, T.G.
Scherf-Clavel, M.
Schoretsanitis, G.
Gründer, G.
Hart, X.M.
Funding for this research was provided by:
Zentralinstitut für Seelische Gesundheit (ZI)
Article History
Received: 19 July 2023
Accepted: 10 October 2023
First Online: 19 October 2023
Declarations
:
: GS has served as a consultant for HLS Therapeutics and Thermo Fisher and has received speaker’s fees from HLS Therapeutics. GG has served as a consultant for Allergan, Boehringer Ingelheim, Institute for Quality and Efficiency in Health Care (IQWiG), Janssen-Cilag, Lundbeck, Otsuka, Recordati, and ROVI. He has served on the speakers’ bureau of Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, and Recordati. He has received grant support from Boehringer Ingelheim, Lundbeck, and Saladax. He is a co-founder and/or shareholder of Mind and Brain Institute GmbH, Brainfoods GmbH, OVID Health Systems GmbH, and MIND Foundation gGmbH. XMH was supported by the Overseas Research Fellow Award by the Japan Society for the Promotion of Science. All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.